Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $55000.0.

  • Benitec Biopharma's Other Non-Current Assets fell 7566.37% to $55000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $55000.0, marking a year-over-year decrease of 7566.37%. This contributed to the annual value of $578000.0 for FY2024, which is 5487.9% down from last year.
  • As of Q1 2025, Benitec Biopharma's Other Non-Current Assets stood at $55000.0, which was down 7566.37% from $42000.0 recorded in Q4 2024.
  • Benitec Biopharma's Other Non-Current Assets' 5-year high stood at $1.3 million during Q2 2023, with a 5-year trough of $42000.0 in Q4 2024.
  • For the 5-year period, Benitec Biopharma's Other Non-Current Assets averaged around $576823.5, with its median value being $567000.0 (2023).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 891111.11% in 2021, then plummeted by 9036.7% in 2024.
  • Over the past 5 years, Benitec Biopharma's Other Non-Current Assets (Quarter) stood at $499000.0 in 2021, then decreased by 5.41% to $472000.0 in 2022, then dropped by 7.63% to $436000.0 in 2023, then plummeted by 90.37% to $42000.0 in 2024, then surged by 30.95% to $55000.0 in 2025.
  • Its Other Non-Current Assets stands at $55000.0 for Q1 2025, versus $42000.0 for Q4 2024 and $482000.0 for Q3 2024.